AUTHOR=Papageorgiou Alexandros K. , Kalt Fabian , Rössler Fabian , Schneider Marcel , Jonas Jan Philipp , Hübel Kerstin , Dusan Harmacek , Mesnard Benoît , Cvijetic Mara , Branchereau Julien , Abdurakhmonov Sarvar , Ismailov Saydimurad , Matkarimov Zohidjon , Akhmedov Aklrom , Frick Lukas , Storni Federico , Gloor Severin , Pawlik Timothy M. , Hoessly David , Koller Michael , Golshayan Déla , Pascual Manuel , Haidar Fadi , Kuhn Christian , Müller Nicolas J. , Johnson David W. , Houben Philipp , Pascher Andreas , Oberholzer Jose , Eshmuminov Dilmurodjon TITLE=Five-year outcomes of machine perfusion versus static cold storage in controlled donation after circulatory death kidney transplantation: a binational cohort study JOURNAL=Transplant International VOLUME=Volume 39 - 2026 YEAR=2026 URL=https://www.frontierspartnerships.org/journals/transplant-international/articles/10.3389/ti.2026.17360 DOI=10.3389/ti.2026.17360 ISSN=1432-2277 ABSTRACT=While hypothermic machine perfusion reduces delayed graft function (DGF) after kidney transplantation, its long-term benefits in controlled donation after circulatory death (DCD) are uncertain in real-world practice. We evaluated whether perfusion improves 5-year death-censored graft survival compared to static cold storage in DCD by benchmarking outcomes against those of donation after brain death (DBD). After analyzing the United Network for Organ Sharing and Swiss Transplant Cohort Study registries, we created a 1:1 propensity-score-matched cohort to balance baseline characteristics. Among 44,552 DCD recipients (34,739 with perfusion; 9,813 with cold storage) and 180,898 DBD controls, the matched 5-year death-censored graft survival rate was 84.8% with perfusion versus 87.4% with cold storage (hazard ratio 1.08; P = 0.19). Perfusion significantly reduced the rate of DGF (35.7% vs. 44.9%; P < 0.001), while the rates of primary nonfunction and acute rejection were comparable. Both DCD groups achieved long-term outcomes equivalent to those of the DBD cohort. In conclusion, while machine perfusion confers a substantial early reduction in delayed graft function, static cold storage continues to deliver excellent 5-year graft survival. Both strategies yield excellent long-term outcomes comparable to those of DBD transplants. Crucially, these findings support expanding DCD programs to include older donors as a vital strategy to increase transplantation rates and reduce waitlist mortality. To optimize outcomes in these older DCD grafts, clinicians should aim to limit donor comorbidity, keep total ischemia time below 12–15 h, and utilize continuous rather than end-ischemic machine perfusion whenever logistically feasible.